Jazz Pharmaceuticals (JAZZ) Interest Expenses (2010 - 2013)

Jazz Pharmaceuticals' Interest Expenses history runs 4 years deep, the most recent figure standing at $614000.0 for Q3 2013.

• In Q3 2013, Interest Expenses fell 44.13% year-over-year to $614000.0; the TTM figure through Jun 2014 stood at $614000.0 (down 82.34% YoY), while the FY2013 annual figure was $1.7 million, down 53.12% from the prior year.
• Interest Expenses was $614000.0 for Q3 2013 at Jazz Pharmaceuticals, up from $385000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $2.3 million in Q4 2012 to a low of -$570000.0 in Q4 2010.
• Historically, Interest Expenses has averaged $604363.6 across 4 years, with a median of $614000.0 in 2013.
• The sharpest annual moves came in 2011 and 2012: Interest Expenses jumped 158.43% in 2011, then sank 63.58% in 2012.
• A 4-year view of Interest Expenses shows it stood at -$570000.0 in 2010, then soared by 215.61% to $659000.0 in 2011, then surged by 243.4% to $2.3 million in 2012, then sank by 72.87% to $614000.0 in 2013.
• The last three Interest Expenses figures came in at $614000.0 (Q3 2013), $385000.0 (Q2 2013), and -$271000.0 (Q1 2013), per Business Quant data.